Safety, compliance and the effects on memory of 48-week Souvenaid use in mild Alzheimer's disease: Results from the Souvenir II and open-label extension study
Scheltens, Philip, Twisk, Jos, Blesa, Rafael, Scarpini, Elio, von Arnim, Christine, Bongers, Anke, Harrison, John, Swinkels, Sophie, Wurtman, Richard, Wieggers, R.L., Vellas, Bruno, Kamphuis, PatrickТом:
8
Мова:
english
Журнал:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2013.08.130
Date:
July, 2012
Файл:
PDF, 73 KB
english, 2012
File converter
Більше результатів пошуку
More benefits 
